24 Participants Needed

Vibrotactile Stimulation for Stroke Rehabilitation

Recruiting at 1 trial location
MA
Overseen ByMazen Al Borno, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: University of Colorado, Denver
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to investigate upper-extremity vibrotactile stimulation with wearables in stroke patients. The main questions it aims to answer are: Are the wearables well-tolerated by patients? Does the vibrotactile stimulation help regain arm function? Participants will wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy. Researchers will compare the treatment group (vibrotactile stimulation wearables) with a control group (conventional therapy only) to see the effects of the vibrotactile stimulation.

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you are under anti-spasticity therapy, you cannot participate in the trial.

What data supports the idea that Vibrotactile Stimulation for Stroke Rehabilitation is an effective treatment?

The available research shows that Vibrotactile Stimulation (VTS) can be an effective treatment for stroke rehabilitation. One study found that daily VTS provided equal or greater relief from muscle stiffness compared to a common treatment using botulinum toxin. Another study using a wearable VTS glove showed potential improvements in hand function for stroke survivors. These findings suggest that VTS can help improve movement and reduce muscle tightness in people recovering from a stroke.12345

What safety data exists for vibrotactile stimulation in stroke rehabilitation?

The available research on vibrotactile stimulation for stroke rehabilitation suggests it is a promising method for improving motor function. The studies reviewed do not specifically report adverse events related to vibrotactile stimulation, indicating it may be a safe option. However, detailed safety data is limited, and more comprehensive studies are needed to fully understand the safety profile of this treatment.25678

Is Vibrotactile Stimulation a promising treatment for stroke rehabilitation?

Yes, Vibrotactile Stimulation is a promising treatment for stroke rehabilitation. It can provide equal or greater relief from muscle stiffness compared to some drugs, and it helps improve hand function in stroke survivors.125910

Eligibility Criteria

This trial is for stroke patients who are currently inpatients at rehabilitation units, had a stroke on one side of the body within the last 2 weeks, and have some arm movement. They should be able to stay for 2-3 weeks in rehab and participate in additional therapy with special gloves and shirts that provide gentle vibrations.

Inclusion Criteria

My arm movement score is between 6 and 58.
I can lift my arm and bend my elbow.
Expected to stay 1-3 weeks in the rehabilitation unit
See 2 more

Exclusion Criteria

Patients that are dependent on pacemakers
Patients that have defibrillators
I have swelling in my arm or a special connection for dialysis on an arm.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy

2-3 weeks
Daily visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

1-3 weeks

Treatment Details

Interventions

  • Vibrotactile Stimulation
Trial Overview The study is testing if wearing gloves and shirts that give off gentle vibrations (vibrotactile stimulation) can help improve arm function after a stroke. Patients will use these wearables for five hours daily along with their regular therapy, while their progress is compared to those receiving only conventional therapy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Vibrotactile StimulationExperimental Treatment1 Intervention
Participants wear vibrotactile stimulation shirts and gloves for 5 hours per day, 7 days per week, during their stay at the rehabilitation unit, which is expected to be between 2-3 weeks. Participants wear the devices after conventional therapy is done for the day.
Group II: ControlActive Control1 Intervention
Participants undergo conventional therapy only.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials
1,842
Recruited
3,028,000+

Findings from Research

The study involved 19 patients with chronic stroke and demonstrated that perturbation-based pinch task training significantly improved sensory function in the affected thumb, as measured by the Semmes-Weinstein monofilament test, immediately after training.
At the 12-week follow-up, the experimental group also showed significant improvements in the box and block test, indicating enhanced motor performance, while the control group had notable improvements in wrist and coordination scores.
Effect of a Novel Perturbation-Based Pinch Task Training on Sensorimotor Performance of Upper Extremity for Patients With Chronic Stroke: A Pilot Randomized Controlled Trial.Hsu, HY., Kuan, TS., Tsai, CL., et al.[2021]
In a study involving 16 chronic stroke survivors, the VTS Glove, which provides vibrotactile stimulation, significantly improved tactile perception and reduced spasticity in the affected hand over an 8-week period.
Participants using the VTS Glove also experienced increased voluntary finger flexion and improved range of motion in the elbow and shoulder, suggesting that wearable stimulation devices can enhance hand function in stroke rehabilitation.
Wearable vibrotactile stimulation for upper extremity rehabilitation in chronic stroke: clinical feasibility trial using the VTS Glove.Seim, CE., Wolf, SL., Starner, TE.[2021]
Mobilization and Tactile Stimulation (MTS) can lead to improvements in upper limb motor function and impairment in chronic stroke survivors, even more than a year after their stroke, as shown in a study with 8 participants.
While all participants showed improvements in motor impairment, clinically significant enhancements in motor function were observed in half of the participants, with recovery often taking several days to manifest after starting the intervention.
Effects of mobilization and tactile stimulation on chronic upper-limb sensorimotor dysfunction after stroke.Winter, JM., Crome, P., Sim, J., et al.[2022]

References

Effect of a Novel Perturbation-Based Pinch Task Training on Sensorimotor Performance of Upper Extremity for Patients With Chronic Stroke: A Pilot Randomized Controlled Trial. [2021]
Wearable vibrotactile stimulation for upper extremity rehabilitation in chronic stroke: clinical feasibility trial using the VTS Glove. [2021]
Effects of mobilization and tactile stimulation on chronic upper-limb sensorimotor dysfunction after stroke. [2022]
Usability Evaluation of a VibroTactile Feedback System in Stroke Subjects. [2022]
Daily Vibrotactile Stimulation Exhibits Equal or Greater Spasticity Relief Than Botulinum Toxin in Stroke. [2023]
A wearable vibrotactile device for upper-limb bilateral motion training in stroke rehabilitation: A case study. [2020]
Safety and Adverse Events following Non-invasive Electrical Brain Stimulation in Stroke: A Systematic Review. [2023]
TheraBracelet Stimulation During Task-Practice Therapy to Improve Upper Extremity Function After Stroke: A Pilot Randomized Controlled Study. [2023]
Effect of vibration characteristics and vibror arrangement on the tactile perception of the upper arm in healthy subjects and upper limb amputees. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Functional magnetic resonance imaging of the human sensorimotor cortex using a novel vibrotactile stimulator. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security